Aripiprazole Terminated Phase 3 Trials for Metabolic Syndromes / Bipolar I Disorder / Schizoaffective Disorders / Schizophrenia Treatment

IndicationsStatusPurposePhase
TerminatedTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT00857818Trial Comparing the Effects of Aripiprazole With Those of Standard of Care on Non-HDL Cholesterol in Patients With Schizophrenia or Bipolar I Disorder Who Have Metabolic Syndrome
NCT01328093A Comparison Study of LY2140023 and Aripiprazole in Schizophrenia Patients
NCT01509053Open-label Study to Compare Hospitalization Rates of Schizophrenic Patients Treated With Oral Antipsychotics Versus IM Depot Aripiprazole
NCT02435836A Follow-on Study of the Long-Term Safety of Aripiprazole in Patients With Chronic Schizophrenia